Kuikui Jiang - Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Dongfeng Road East 651#, Guangzhou, 510060, China.

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Significance of Serum Estradiol Monitoring in Women Receiving Adjuvant Aromatase Inhibitor for Hormone Receptor-Positive Early Breast Cancer

Shuqin Dai,Xingping Wu, Xuefang Huang,Jibin Li, Xi Wang,Shusen Wang,Jun Tang,Yanxia Shi,Xiaoming Xie, Fei Xu,Peng Liu,Jiajia Huang,Xinhua Xie,Xin An,Meiting Chen, Rouxi Hong,Wen Xia,Qiufan Zheng,Kuikui Jiang,Yongyi Zhong,Zhongyu Yuan,Yuanyuan Huang,Xiwen Bi, Cong Xue

Breast (Edinburgh, Scotland)（2024）

引用0浏览0WOS引用

Pyrotinib and Trastuzumab Plus Palbociclib and Fulvestrant in HR+/HER2+ Breast Cancer Patients with Brain Metastasis

Dongshao Chen,Fei Xu,Yongkui Lu,Wen Xia,Caiwen Du,Dun Xiong,Dong Song,Yanxia Shi, Zhongyu Yuan,Qiufan Zheng,Kuikui Jiang,Xin An,Cong Xue,Jiajia Huang,Xiwen Bi,Meiting Chen,Jingmin Zhang,Shusen Wang,Ruoxi Hong

npj Breast Cancerno. 1 (2024)

引用0浏览0WOSNATURE引用

Phase I Study of TQB3728 Tablets, an Oral Inhibitor of Apoptosis Proteins in Patients with Advanced Solid Tumor

Qiufan Zheng, Su Li,Wen Xia, Ruoxi Hong,Kuikui Jiang,Jiajia Huang, Fei Xu, Lifan Tu, Shaonan Tang, Mengjia Huang,Shusen Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? an Exploratory Analysis of the SYSUCC-001 Trial

Ying Chen, Wen-Xia Li,Jia-Hua Wu,Geng-Hang Chen,Chun-Min Yang,Hai Lu,Xi Wang,Shu-Sen Wang,Heng Huang,Li Cai,Li Zhao,Rou-Jun Peng,Ying Lin,Jun Tang,Jian Zeng,Le-Hong Zhang,Yong-Li Ke, Xian-Ming Wang,Xin-Mei Liu,An-Qin Zhang,Fei Xu,Xi-Wen Bi,Jia-Jia Huang, Ji-Bin Li,Dan-Mei Pang,Cong Xue,Yan-Xia Shi,Zhen-Yu He,Huan-Xin Lin,Xin An,Wen Xia,Ye Cao,Ying Guo,Ruo-Xi Hong,Kui-Kui Jiang,Yong-Yi Zhong, Ge Zhang,Piyawan Tienchaiananda, Masahiro Oikawa,Zhong-Yu Yuan,Qian-Jun Chen

BREAST CANCER-TARGETS AND THERAPY (2024): 223-231

引用0浏览0WOS引用

Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study

Kuikui Jiang,Ruoxi Hong,Wen Xia,Qianyi Lu,Liang Li, Jianhao Huang,Yanxia Shi,Zhongyu Yuan,Qiufan Zheng,Xin An,Cong Xue,Jiajia Huang,Xiwen Bi,Meiting Chen,Jingmin Zhang,Fei Xu,Shusen Wang

Cancer Research and Treatmentno. 2 (2024): 513-521

引用0浏览0WOS引用

Construction and Validation of a Macrophage-Related Prognostic Index to Predict the Overall Survival in Patients with Early-Stage Triple-Negative Breast Cancer

Hanjia Luo,Ruoxi Hong,Yadong Xu,Qiufan Zheng,Wen Xia,Qianyi Lu,Kuikui Jiang,Fei Xu,Miao Chen,Dingbo Shi,Wuguo Deng,Shusen Wang

GLAND SURGERY（2023）

引用0浏览0WOS引用

Clinicopathological Characteristics and Genomic Profiling of Pure Mucinous Breast Cancer

S. Wang,Q. Lu, H. Zhou,P. Sun, K. Shao,K. Lee, F. Xu,W. Xia,K. Jiang

Annals of Oncology (2023): S312-S313

引用0浏览0WOS引用

Supplementary Data from Trastuzumab Plus Endocrine Therapy or Chemotherapy As First-line Treatment for Patients with Hormone Receptor–Positive and HER2-Positive Metastatic Breast Cancer (SYSUCC-002)

Xian-Sheng Hua,Xiwen Bi,Jianli Zhao, Yinghuan Shi,Ying Li, Zhiyong Wu,Yuanqi Zhang,Lehong Zhang,An-Qing Zhang,Heng Huang,Xinmei Liu,Xu Fei,Ying Guo, Wen Xu,Ruoxi Hong,Kuikui Jiang, Cong Xue, An Xu,Yong-Yi Zhong,Shusen Wang,Jiajia Huang,Zhongyu Yuan

openalex（2023）

引用0浏览0引用

Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors

Kuikui Jiang,Danyang Zhou,Ruoxi Hong,Qianyi Lu,Fei Xu,Wen Xia,Qiufan Zheng,Shusen Wang

Journal of Personalized Medicine（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn